- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Bonesupport Holding
Market Cap: SEK 16.2b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 246.40
7D
-8.3%
1Y
0.08%
Biotage
Market Cap: SEK 11.4b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 141.90
7D
0.1%
1Y
-23.7%
AddLife
Market Cap: SEK 22.6b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 185.50
7D
0.5%
1Y
63.4%